The DOI matches its Crossref record; 76 of the 80 references it cites were found in a registry or an index; 37 of the 111 sources its claims cite were checked for support.
Lactobacillus Bacteremia and Probiotics: A Review
Open accessAbstract
Lactobacilli are widely found in nature, are commensal microbes in humans, and are commonly used as probiotics. Concerns about probiotic safety have arisen due to reports of bacteremia and other Lactobacillus-associated infections. We reviewed the literature for articles on the pathogenicity of Lactobacillus spp. bacteremia and reports of probiotics in these patients. Our aim is to review these articles and update the present knowledge on the epidemiology of Lactobacillus spp. bacteremia and determine the role of probiotics in Lactobacillus bacteremia. Lactobacillus bacteremia is infrequent but has a higher risk of mortality and risk factors, including severe underlying diseases, immune system suppression, admission to intensive care units, and use of central venous catheters. A variety of Lactobacillus species may cause bacteremia and may or may not be associated with probiotic exposure. To determine if oral probiotics are the source of these infections, the blood isolates and the oral probiotic strain(s) must be compared by sensitive identification methods. The prevalence of Lactobacillus bacteremia is infrequent but is more common in patients taking probiotics compared to those not taking probiotics. Three probiotics (Lacticaseibacillus rhamnosus GG, Lactiplantibacillus plantarum, and Lacticaseibacillus paracasei) were directly linked with blood isolates from bacteremia patients using molecular identification assays.
Overview
CoChat Summary
TL;DR
This review finds Lactobacillus bacteremia (LB) is infrequent but associated with high mortality and risk factors including severe underlying disease, immunosuppression, ICU admission, and central venous catheters. Probiotic strains are an infrequent source: only 23 of 75 reviewed LB cases had a blood isolate identical to the probiotic strain taken, with Lacticaseibacillus rhamnosus GG most commonly implicated.
Key findings
- LB prevalence is low: 0.1–0.2% of blood culture isolates from hospitalized patients and 0.5% from immunocompromised patients; one hematopoietic cell transplant cohort reported 1.6 cases/100,000 patient days, and Finland averaged 0.29 cases/100,000 inhabitants/year from 1995–2000 despite increased Lcb. rhamnosus GG use.
- Mortality is high but often attributed to underlying conditions: estimated at 30%; Salminen et al. found 26% mortality at one month and 48% at one year; Husni et al. found 44% died during hospitalization but only one death was directly attributable to LB; Franko et al. reported 23.7% case fatality by day 28 and 45% at one year.
- Risk factors include severe underlying diseases (OR = 15.8 for mortality), while treatment with antibiotics effective in vitro was associated with lower mortality (OR = 0.22); in one review, 49% were in ICU, 40% had cancer, 37% immunosuppression, 29% central venous devices, and 39% had ≥2 risk factors.
- Among 75 total LB cases reviewed, 23 had a blood isolate identical to the probiotic strain taken; three probiotics were directly linked by molecular identification: Lcb. rhamnosus GG, Lactiplantibacillus plantarum, and Lcb. paracasei. In one pediatric ICU study, 6/522 (1.1%) patients receiving Lcb. rhamnosus GG developed LB versus 2/21,652 (0.009%) not receiving it; in pediatric hematopoietic cell transplant patients, 6/34 (17.6%) given a probiotic developed LB, with three matched to the probiotic blend.
Methods
- Literature review from 1980 to 2023 on Lactobacillus spp. bacteremia pathogenicity and probiotic reports in these patients.
- Search terms included Lactobacillus, bacteremia, probiotics, risk factors, treatment, antibiotic susceptibilities, safety, epidemiology, sepsis, endocarditis, and infection.
- Inclusion criteria were case reports, case series, observational studies, and reviews; exclusion criteria were non-Lactobacilli bacteremias, fungemias, or other diseases; references from reviews and published papers were also queried.
Limitations
- The paper states that many reports attempting to link probiotic strains to LB isolates failed to prove correlation because of incomplete identification of strains; molecular identification of both the blood isolate and the probiotic strain is needed.
- The paper states that clinical experience and clinical trials on optimal antibiotic treatments are lacking, and that more studies on length of hospital stay, healthcare-associated costs, and long-term surveillance of probiotic use and LB are warranted.
- Evident from the text: this is a literature review without a described systematic search or meta-analysis, and findings depend on heterogeneous case reports, case series, and observational studies with variable identification methods and incomplete strain reporting; LB may also be underdiagnosed because lactobacilli are difficult to culture and identify and are often deemed contaminants.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
24 Valid · 2 Not valid · 33 Not checked · 26 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“In general, second-generation cephalosporin and cefuroxime showed greater activity against lactobacilli, compared with third-generation cephalosporin and ceftriaxone, which is in accordance with earlier observations.”
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.5. Treatment and Susceptibility
What the sources say
- Supportedcites [23] Salminen, 2006, Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates, Clin. Infect. Dis. source
The Discussion directly states that cefuroxime, a second-generation cephalosporin, showed higher activity against lactobacilli than ceftriaxone, a third-generation cephalosporin. The β-Lactam antimicrobials section likewise reports generally highest activity for cefuroxime and lowest for ceftriaxone among the cephalosporins tested. (LLM, conf=0.95)
plainstates an associationn = 85- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The most common species isolated from LB blood samples is Lcb. rhamnosus GG (ATCC53103) [6,7,15,22,23,24].”
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.2. Etiologies of LB
What the sources say
- Not checked — no full text of the sourcecites [6] Husni, 1997, Lactobacillus bacteremia and endocarditis: Review of 45 cases, Clin. Infect. Dis. source
- Partly supportedcites [7] Rossi, F., Amadoro, C., Gasperi, M., and Colavita, G. (2022). Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications. Nutrients, 14. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) reports blood isolates identified as L. rhamnosus in patients receiving the GG probiotic, and Section 5 links blood isolates in one case to L. rhamnosus GG (ATCC 53103). Neither passage establishes that the GG strain was the most common isolate across lactobacilli blood samples; Section 4 also describes L. rhamnosus blood isolates more similar to other strains than to GG. (LLM, conf=0.86)
- Partly supportedcites [15] Doron, 2015, Risk and safety of probiotics, Clin. Infect. Dis. sourceExperimental — accuracy not yet measured
The surveillance passage (labelled Abstract in our copy; no page given) reports that 11 of 89 blood isolates appeared identical to L. rhamnosus GG by one test. It does not say GG was the most common isolate, and it notes that subsequent testing found phenotypic differences between those isolates and probiotic GG. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [22] Lu, 1999, Clones of Lactobacillus casei and Torulopsis glabrata associated with recurrent abdominal wall abscess, J. Formos. Med. Assoc.
- Partly supportedcites [23] Salminen, 2006, Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates, Clin. Infect. Dis. sourceExperimental — accuracy not yet measured
The Results report that L. rhamnosus was the most numerous species (46 isolates), including 22 classified as L. rhamnosus GG type. The Identification section defines “GG type” by an indistinguishable PFGE pattern; the Isolates and patients section identifies ATCC 53103 as a separate reference strain used in testing. The paper therefore does not establish that the most common blood isolate was the exact ATCC 53103 strain. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [24] Gouriet, 2012, Lactobacillus rhamnosus bacteremia: An emerging clinical entity, Eur. J. Clin. Microbiol. Infect. Dis. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The source of these infections has sometimes been attributed to the use of Lactobacillus-containing probiotics [9,10,11].”
§ Lactobacillus Bacteremia and Probiotics: A Review > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [9] Salminen, 2004, Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG, Clin. Infect. Dis. source
- Supportedcites [10] Cohen, 2016, Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations, Transpl. Infect. Dis. source
The Discussion reports rare cases of Lactobacillus bacteremia after probiotic supplementation, supporting the claim that probiotics have sometimes been implicated. It also cautions that the authors could not determine whether probiotic use caused infections in their own cohort. (LLM, conf=0.90)
- Supportedcites [11] Dani, 2016, Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review, AJP Rep. source
The Discussion reports two neonatal cases of L. rhamnosus GG sepsis during enteral supplementation and says probiotic supplementation most likely caused the sepsis in these patients and previously reported cases. It also describes enteral administration as the likely portal of entry, supporting the claim that these infections have sometimes been attributed to Lactobacillus-containing probiotics. (LLM, conf=0.94)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other Lactobacillus species have been less frequently reported: Lcb. paracasei [7], Lactobacillus (L.) acidophilus [7,15], L. jensenii [7,23,26], Lactiplantibacillus (Lpb.) plantarum [7,27], and Limosilactobacillus (Lsb.) fermentum [7,23].”
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.2. Etiologies of LB
What the sources say
- Supportedcites [7] Rossi, F., Amadoro, C., Gasperi, M., and Colavita, G. (2022). Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications. Nutrients, 14. source
The Abstract (page not available in our copy) lists all five species among reported lactobacilli infections. Each has fewer reported cases than Lacticaseibacillus rhamnosus, supporting the statement that they were less frequently reported. (LLM, conf=0.92)
- Partly supportedcites [15] Doron, 2015, Risk and safety of probiotics, Clin. Infect. Dis. sourceExperimental — accuracy not yet measured
The References (page not provided) include a report of L. acidophilus bacteremia, supporting that species’ inclusion. The Abstract’s strain table names L. paracasei and L. plantarum as probiotics studied, not as causes of bacteremia. Our copy does not substantiate the claimed relative frequency or identify L. jensenii and L. fermentum as reported causes. (LLM, conf=0.82)
- Partly supportedcites [23] Salminen, 2006, Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates, Clin. Infect. Dis. sourceExperimental — accuracy not yet measured
The Results and isolate-count tables (pages not supplied) document blood isolates of L. fermentum, L. jensenii, and L. plantarum, with fewer isolates than L. rhamnosus. Our copy does not document L. paracasei or L. acidophilus among the blood isolates; paracasei appears only in a reference about peritonitis, not bacteremia. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [26] Chazan, 2008, Bacteremia and pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis, Isr. Med. Assoc. J.
- Not checked — no full text of the sourcecites [27] Matsuura, 2021, Lactobacillus bacteremia: A diagnostic clue of rectal cancer, QJM source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“One study reviewed cases reported over 5.5 years at a hospital in Boston, Massachusetts, and found of 21,652 patients admitted to their ICU who were not taking any probiotics, only two (0.009%) cases of LB were detected, which were caused by either L. acidophilus or Lpb. plantarum, but the specific strain was not reported [47].”
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.6. Role of Probiotics in LB
What the sources say
- Partly supportedcites [47] Yelin, 2019, Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients, Nat. Med. sourceExperimental — accuracy not yet measured
The paper reports two cases of Lactobacillus bacteremia (0.009%) among 21,652 ICU patients who did not receive an LGG-containing probiotic. It does not define that entire group as taking no probiotics: the Patient inclusion criteria and clinical data section says 645 ICU patients received probiotics, but only 522 received one containing LGG. The case count and rate match, but the claim broadens the comparison group incorrectly. (LLM, conf=0.91)
plainn = 21,652- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 11 with their cited sources checked
Create a free account to see all 85 claims and to verify the 5 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 10
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.7. Safety of Probiotics
“expectations that it will reach USD 72.9 billion by 2030”
§ Lactobacillus Bacteremia and Probiotics: A Review > References
“67. Allied Market Research. 2022. Probiotics Market Expected to Reach $73.9 Billion by 2030”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Husni et al. reviewed cases of 45 patients over 15 years with clinically significant LB [6]. Twenty-two patients (44%) died during their hospitalization;”
§ Lactobacillus Bacteremia and Probiotics: A Review > 3. Results > 3.4. Consequences of LB
Reported 44 · recomputed 48.888889
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Zheng, J., Wittouck, S., Salvetti, E., Franz, C. M. A. P., Harris, H. M. B., Mattarelli, P., O’Toole, P. W., Pot, B., Vandamme, P., Walter, J., et al. (2020) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.004107 · Cited by 3,313 · cited 1×
“Recently the identification of the genus Lactobacillus has been divided into 23 genera, >250 species, and 57 subspecies [17].”
BackgroundBeachey, E. H. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.3.325 · Cited by 1,411
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Demonstration of safety of probiotics—A review
Salminen, S. (1998) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(98)00128-7 · Cited by 884
van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640 · cited 1×
“Previous reviews and clinical practice guidelines have urged caution for probiotic use due to safety concerns [7,16,64].”
BackgroundMcFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00124 · Cited by 609
Self-citationLactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 2×
“rhamnosus GG (ATCC53103) PCR 2 2 6 yr 6 wk AAD, CVC Yes No [57]”
BackgroundPathogenic relevance of Lactobacillus: A retrospective review of over 200 cases
Cannon, J. P., Lee, T. A., Bolanos, J. T., & Danziger, L. H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1253-y · Cited by 478 · cited 4×
“From a literature review of 241 cases of lactobacilli infections (129 cases of LB, 73 cases lactobacilli endocarditis, and 39 cases of localized lactobacilli infections), none were associated with probiotic exposure [25].”
BackgroundInfluentialSalminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 3×
“found that in patients with LB, the mortality was 26% at one month and 48% at one year [9].”
BackgroundInfluential
Research works printed but not linked: 1
- 2019, [Sepsis due to Lactobacillus reuteri in an extreme preterm newborn: Case report], Arch. Argent Pediatr., 117, e509
Cited by
Zhang, L., Xu, J.-Y., Xing, Y., Wu, P., Jin, Y.-W., Wei, W., Zhao, L., Yang, J., Chen, G., & Qin, L. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127821 · Cited by 56
Probiotics and their applications in functional foods: a health perspective
Amin, M. R., Biswas, A. P., Tasnim, M., Islam, M. N., & Azam, M. S. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101193 · Cited by 51
Engineered bacteria in tumor immunotherapy
Chen, H., Zhu, Y., Zhang, C., Hu, L. T., & Yang, K. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216817 · Cited by 44
Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics
Valeriano, V. D., Lahtinen, E., Hwang, I., Zhang, Y., Du, J., & Schuppe‐Koistinen, I. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1363089 · Cited by 59
“…organ transplantation), urogenital pathologies, congenital and valvular heart diseases or those who have undergone invasive procedures, that may be more susceptible to probiotic use (Salminen et al., 2004; Rossi et al., 2022; Salminen et al., 2006; Bapna et al., 2023; Kullar et al., 2023).”
Type 2 Diabetes and the Multifaceted Gut-X Axes
Guo, H., Pan, L.-T., Wu, Q., Wang, L., Huang, Z., Wang, J., Wang, L., Fang, X., Dong, S., Zhu, Y., et al. (2025) · Nutrients · doi:10.3390/nu17162708 · Cited by 43
Astley, R., Mursalin, M. H., Coburn, P. S., Livingston, E. T., Nightengale, J. W., Bagaruka, E., Hunt, J. J., & Callegan, M. C. (2023) · Microorganisms · doi:10.3390/microorganisms11071802 · Cited by 33
Xu, R., Yu, Y., & Chen, T. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101044 · Cited by 31
“Identifying strains quickly, conducting susceptibility tests, and providing timely treatment can improve patient outcomes (Cannon et al., 2005; Kullar et al., 2023), as reliance solely on empirical therapies might worsen conditions.”
Exploring the future of probiotics with innovations in delivery systems and market insights
Ramírez, A., Bermúdez-Luque, A., Román‐Camacho, J. J., Martín-García, F. J., Moreno‐García, J., Güngörmüşler, M., & Ruiz-Castilla, F. J. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107029 · Cited by 34
Action and immunomodulatory mechanisms, formulations, and safety concerns of probiotics
Ashaolu, T. J., Greff, B., & Varga, L. (2024) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2024-006 · Cited by 27
Recent Records on Bacterial Opportunistic Infections via the Dietary Route
Rossi, F., Santonicola, S., Amadoro, C., Marino, L., & Colavita, G. (2023) · Microorganisms · doi:10.3390/microorganisms12010069 · Cited by 37
“The role of lactobacilli as opportunistic pathogens was summarized in recent reviews that illustrated the routes of infection, types of illnesses caused, and some genetic traits that could discriminate potentially pathogenic strains [2,90].”
BackgroundFunctional Cheeses: Updates on Probiotic Preservation Methods
Araujo, H. C. S., de Jesus, M. S., Sandes, R. D. D., Neta, M. T. S. L., & Narain, N. (2023) · Fermentation · doi:10.3390/fermentation10010008 · Cited by 41
Gut microbiome and its metabolites in liver cirrhosis: mechanisms and clinical implications
Chang, L., Liu, Y., Li, H., Yan, J., Wu, W., Chen, N., Ma, C., Zhao, X., Chen, J., & Zhang, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1717696 · Cited by 29
Gut-lung immunometabolic crosstalk in sepsis: from microbiota to respiratory failure
Li, Q., Song, X.-C., Li, K., & Wang, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1685044 · Cited by 34
“Clinical observations have found that in patients with immunosuppression or severely damaged intestinal barriers, the use of probiotics (especially Lactobacillus GG) may increase the risk of bacteremia (194–196).”
Peng, Z., Wang, D., He, Y., Wei, Z., Xie, M., & Xiong, T. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10222-6 · Cited by 20
“The leakage of probiotics from gut to blood can induce bacteremia [105, 106], more seriously, sepsis, pneumonia, and liver abscess [107].”
Qin, J., Ma, Y., Wang, C., Li, H., Zou, Z., Zhang, Y., Ma, J., & Du, R. H. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103904 · Cited by 15
Vidhate, P., Wakchoure, P., Borole, S., & Khan, A. A. (2024) · American Journal of Translational Research · doi:10.62347/igwr5474 · Cited by 18
“Studies reported that L. rhamnosus GG, L. plantarum , and L. paracasei were involved in bacteremia with certain other bacteria [70], especially among immunocompromised patients.”
Addissouky, T. A. (2024) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-024-01244-9 · Cited by 15
“Less viable pathogens leads to reduced risk of acute inflammation and postoperative infections (Kullar et al. 2023).”
BackgroundCazzaniga, M., Cardinali, M., Pierro, F. D., Zonzini, G. B., Palazzi, C. M., Gregoretti, A., Zerbinati, N., Guasti, L., & Bertuccioli, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042306 · Cited by 15
“…use of CBM588 by other authors in critically ill patients [54], against much more numerous cases found for Lactobacilli and Bifidobacteria [55], could suggest the need to plan and carry out clinical evaluations that can provide us with even more uniform and certainly more numerous data…”
BackgroundGao, X., Zhu, Z., Bao, Y., Li, Y., Zhu, W., He, X., Ge, X., Huang, W., Wang, H., Wei, W., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00950-w · Cited by 19
“Bifidobacteria and Lactobacillus rhamnosus have been shown to have beneficial functions for human health like anti-cancer, immune regulation, and so on [34, 35].”
BackgroundCRISPR-engineered microbiome: living therapeutics revolutionize blood cancer immunotherapy
Cheng, F., Samarkhazan, H. S., & Khazaei, Y. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00882-9 · Cited by 18
Antidiabetic effects and mechanism of γ-polyglutamic acid on type II diabetes mice
Li, Y., Zhang, W., Tang, C. S., Wang, C., Liu, C., Chen, Q., Yang, K., Gu, Y., Lei, P., Xu, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129809 · Cited by 14
Li, Y., Zhen, S., Cao, L., Sun, F., & Wang, L. (2023) · Animals · doi:10.3390/ani13182958 · Cited by 16
“However, limited reports of Lactobacillus-associated infections have raised concerns about the safety of Lactobacillus [6].”
BackgroundThe role of Lactobacillus plantarum in oral health: a review of current studies
Huang, X., Bao, J., Yang, M., Li, Y., Liu, Y., & Zhai, Y. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2411815 · Cited by 18
“However, it is crucial to note that further research is necessary to gain a comprehensive understanding of the potential implications and ensure the safety of probiotic L. plantarum usage [126].”
BackgroundTargeting the immuno-inflammatory-microbial network: a key strategy for sepsis treatment
Xu, Y., Wang, J., Yuan, R. R., Qin, Z., Long, K., & Gao, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575516 · Cited by 24
Zhou, Q., Chi, J., Yang, J., Dong, X., Guo, J., Lian, F., Mamun, A. A., Chen, T., Zhang, H., Chen, J., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.001 · Cited by 12
“More critically, when probiotics enter the bloodstream through damaged blood vessels, they may cause systemic infections such as bacteremia [15,16], undermining both the translational efficiency and safety of clinical applications.”
Eze, U. J., Lal, A., Elkoush, M. I., Halytska, M., & Atif, S. M. (2024) · Cureus · doi:10.7759/cureus.54879 · Cited by 19
Kong, L., Hu, X., Xia, D., Wu, J., Zhao, Y., Guo, H., Zhang, S., Qin, C., Wang, Y., Li, L., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123060 · Cited by 12
Natural polysaccharides-based postbiotics and their potential applications
Du, W., Martino, L. D., & Li, J. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00230 · Cited by 13
Deng, Z.-H., Li, X., Liu, L., Zeng, H.-M., Chen, B.-F., & Peng, J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i47.5097 · Cited by 10
Wang, F., Chen, W., Jia, Y., He, T., Wu, S., Xiang, J., Chen, R., Jiang, Q., Yu, T., Lan, Y., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70994 · Cited by 17
“Molecular identification analyses have shown that probiotic isolates re-lated to bacteremia can be found in affected patients, who are predominantly immunocompromised [126].”
Yu, Q., Chang, Z., Sun, Y., Ma, F., He, H., Lu, Y., Tai, Z., Zhu, Q., Wen, J., Chen, Z., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114016 · Cited by 12
Liu, D., Wang, X., & Zhang, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154948 · Cited by 12
Fernández, L., Orgaz, B., & Rodríguez, J. M. (2024) · Foods · doi:10.3390/foods13244024 · Cited by 10
Lim, S. Y. M., Chong, E.-J., Mah, W. Y., Pan, Y., Fang, C.-M., Murugaiah, C., & Alshagga, M. A. (2025) · Letters in Applied Microbiology · doi:10.1093/lambio/ovaf024 · Cited by 11
Toshimitsu, T., & Irie, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16273 · Cited by 11
“33 Although systemic inflammation may worsen due to the intake of pro-biotics, no serious concern was reported in the studies included in this review as long as probiotics were administered in the range of approximately 1 (cid:1) 10 9 /day to 1 (cid:1) 10 11 /day (Table 1).”
The emerging role of the gut microbiota in vaccination responses
Decker, V., Qureshi, K., Roberts, L. A., Powell, N., Marchesi, J. R., Mullish, B. H., & Alexander, J. L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2549585 · Cited by 16
“101 Other probiotic preparations including Lacticaseibacillus rhamnosus GG (LGG) , Lactiplantibacillus plantarum and Pediococcus acidilactici KABP021 have shown promise in reducing the severity of active COVID-19 infection.”
Gioula, G., & Exindari, M. (2025) · Vaccines · doi:10.3390/vaccines13111116 · Cited by 13
“Probiotics are generally safe in healthy populations, but caution is warranted in immunocompromised individuals, preterm infants, and critically ill patients, where cases of bacteremia have been reported [41].”
Gut microbiome, a novel precision medicine biomarker for hepatocellular carcinoma
Chen, P., Devkota, S., Shiao, S. L., Hendifar, A. E., & Yang, J. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568962 · Cited by 13
Fujii, T., Kezuka, C., KAWAGUCHI, Y., Yamakawa, S., KONDO, N., Funasaka, K., Hirooka, Y., & Tochio, T. (2024) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0238 · Cited by 8
“Lactobacilli, widely found in nature, are commensal bacteria in humans, and are commonly used as probiotics [19].”
Wang, Y., Li, W., Wang, X., Hu, Q., Kong, J., wang, X., Lan, Z., Wang, C., & Zhang, Y. (2024) · Food Chemistry X · doi:10.1016/j.fochx.2024.101171 · Cited by 7
Yan, L., Sha, A., Lv, X., Lv, Z., Zhang, B., Choct, M., Guo, Y., Wang, Z., Yan, B., & Li, Y. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104653 · Cited by 18
“According to Kullar et al. (2023), as a crucial bacterium inhabiting the intestinal tract of both humans and animals, Lactobacillus is instrumental in maintaining the equilibrium of the gut microbiota, bolstering immune response, and facilitating nutrient assimilation.”
Zhou, B., Xing, Z., Wang, Y., Guan, X., Wang, F., Yin, J., Li, Z., Zhao, Q., Hou, H., & Sang, X. (2025) · Foods · doi:10.3390/foods14132373 · Cited by 8
“Among various probiotic strains, L. plantarum has demonstrated particular promise due to its GRAS status and versatile fermentation capabilities [7,8].”
An Overview of Nanoparticle Properties and Their Bioactivity
Nwankwo, C. E., Adewuyi, A., & Osho, A. (2023) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2023/v32i5814 · Cited by 7
Nagaoka, K., Iwanaga, N., Takegoshi, Y., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04743-1 · Cited by 7
“Although recent studies have suggested the potential virulence of these anaerobes [32–34], the exclusion of AB due to these anaerobes may have limited our findings.”
Li, S., Tantibhadrasapa, A., Buddhasiri, S., Boonpan, P., Sukjoi, C., Mongkolkarvin, P., Nakphaichit, M., Nitisinprasert, S., & Thiennimitr, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051821 · Cited by 12
“Three Gram-positive bacteria probiotics ( Lacticaseibacillus rhamnosus GG, Lactiplantibacillus plantarum , and Lacticaseibacillus paracasei ) had been reported as possible causative agents of bacteremia in patients who were orally taking live Lactobacilli [21].”
Sun, J., Wu, Y., Li, X.-L., Xie, W., Xiong, Q., Jiang, C., Tang, S.-W., Peng, G., & Zheng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1651015 · Cited by 7
Gut Microbiota and Probiotics in Perioperative Management: A Narrative Review
Kurdi, M. S., Bajwa, S. S., Sharma, R. B., & Choudhary, R. (2024) · Cureus · doi:10.7759/cureus.68404 · Cited by 12
“Lacticaseibacillus rhamnosus GG, Lactiplantibacillus plantarum and Lacticaseibacillus paracasei have been directly linked with bacteraemia [84].”
BackgroundMcFarland, L. V., Goldstein, E. J. C., & Kullar, R. (2023) · Microorganisms · doi:10.3390/microorganisms11061534 · Cited by 7
“A review of Lactobacilli bacteremia only found 23 cases when the Lactobacilli blood isolate was identical to the oral Lactobacilli probiotic strain [74].”
BackgroundInfluentialSelf-citationFukao, M., Tagawa, K., Sunada, Y., UEHARA, K., Sugimoto, T., Zendo, T., Nakayama, J., & Segawa, S. (2025) · Microorganisms · doi:10.3390/microorganisms13020388 · Cited by 6
“Safety Assessment and Clinical Trial Outcomes Safety assessment of new probiotic candidates requires further evaluation since previous studies have reported infections owing to the consumption of probiotics [56].”
Yang, Z., Wang, X., Wu, S., Yu, X., Du, P., Zhang, G., Li, C., & Liu, L. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107069 · Cited by 5
Souza, V. D. S., Manhães‐de‐Castro, R., Pereira, S. D. C., de Silveira, B. S., Calado, C. M. S. D. S., Gouveia, H. J. C. B., Coq, J., & Toscano, A. E. (2025) · Cells · doi:10.3390/cells14141063 · Cited by 7
“However, certain Lactobacillus strains have been implicated in excessive immune activation or opportunistic infections, especially in immunocompromised individuals [63,64].”
Alhubail, M., McBain, A. J., & O’Neill, C. A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00347-24 · Cited by 8
Necrotising fasciitis with extensive necrosis caused by Lactobacillus: a case report
Nagayama, J., Sato, T., Ishida, T., Kouji, K., & Nakamura, M. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09291-3 · Cited by 7
Safety Assessment and Probiotic Potential of a Novel Species Lactobacillus xujianguonis
Lin, X., Zhou, X., Lu, Y., Yuan, Z., Lan, R., Du, Y., Liu, L., & Xu, J. (2025) · Nutrients · doi:10.3390/nu17213474 · Cited by 8
Nutritional therapy in human immunodeficiency virus (HIV) infection
Blaauw, R. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.10.012 · Cited by 6
Ukai, K., Okamoto, K., Ichinose, A., Yoshida, M., Higurashi, Y., Yoneda, R., Yamamoto, S., & Asahara, T. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004548 · Cited by 5
Peña-Ocaña, B. A., Silva-Flores, M., Toya, S., García-Gálvez, L., Hernández‐Esquivel, L., Robledo‐Cadena, D. X., Barrera‐Oviedo, D., Pérez-Torres, I., Tostado-Islas, O., Maeda, T., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117667 · Cited by 5
Evaluation of Acute and Sub-Chronic Toxicity of Lactobacillus rhamnosus GG in Sprague-Dawley Rats
Vedam, V., Banik, U., Sabesan, G. S., Adhikary, A. K., & Parasuraman, S. (2024) · Advanced Biomedical Research · doi:10.4103/abr.abr_13_24 · Cited by 6
“[16,17] Among the various bacterial strains, L. rhamnosus strain is generally considered safe with minimum side effects.”
Farella, I., Fortunato, M., Martinelli, D., Carlo, C. D., Sparapano, E., Stolfa, S., Romanelli, F., Laurentiis, V. D., Martinotti, S., Capozzi, L., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13020265 · Cited by 6
“These bacteria are highly diverse, and their identification often requires molecular methods due to their taxonomical complexity [12].”
Lactobacillus plantarum liver abscess following ERCP: a case report and review
Ren, W., Wei, Y., Lian, G., Yang, C., & Liu, Y. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11094-z · Cited by 6
“There has been an increasing number of trials exploring the therapeutic effects of Lactobacillus plantarum in various diseases [7].”
Wu, W., Wang, Z., Ding, L., Zhang, Y., Ma, K., Li, H., Hou, Y., & Ding, W. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10729-6 · Cited by 8
Carrega, G., Ricciardi, B., Bartolacci, V., Brenci, S., Izzo, M., Morelli, P., Tigano, S., & Riccio, G. (2023) · PubMed Central · doi:10.53854/liim-3103-13 · Cited by 6
“The most severe cases are described in patients with severe underlying conditions and in preterm infant [8-13].”
BackgroundShawon, J., Pell, L. G., Kabir, M., Evans, K. C., Hasan, M. M., Li, G., Qamar, H., Starke, C. W. E., Kurukulasuriya, S., Mahmud, A. A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02711-23 · Cited by 3
Lin, Y., Chih-Ying, W., Tsai, Y., Chen, C., Chang, T.-C., Chen, L., Chen, H.-T., Hsu, C., & Tang, C. (2024) · Aging · doi:10.18632/aging.206101 · Cited by 6
Kowalik, K., Kulig, K., Karnas, E., Woźnicka, O., Zuba‐Surma, E. K., Pyza, E., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2024.49 · Cited by 4
Park, C. Y., Park, O.-J., Kwon, Y., Lee, J., Yun, C., & Han, S. H. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10441-x · Cited by 5
“Consistent with this, in certain clinical cases, Lactobacillus species are implicated as opportunistic pathogens causing bacteremia, dental abscesses, and prosthetic knee infections [41–43].”
Kawamoto, Y., Suzuki, M., Iwata, M., & Uehara, Y. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-261578 · Cited by 3
Lactobacillus Bacteremia and Endovascular Infections: A Retrospective Study of 100 Patients
Radcliffe, C. V., Anahtar, M. N., Hohmann, E. L., Turbett, S. E., Dugdale, C. M., & Paras, M. L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf466 · Cited by 6
Ginting, N., Mirwandhono, E., Ketaren, N. B., et al. (2025) · Veterinary World · doi:10.14202/vetworld.2025.1224-1233 · Cited by 2
Good bacteria gone awry: probiotic-induced bacteremia in a vulnerable patient - a unique case report
Machchhar, R. R., Hernandez, A. T., Meusburger, C., Godavarthy, P. K., Vennapusa, J. R., Grant, C., Hasan, B., & Rothberg, M. (2025) · Infectious Diseases and Herbal Medicine · doi:10.4081/idhm.2025.583 · Cited by 4
Zhang, M., Shu, Y., Yang, J., Sang, S., Liu, X., Li, Y., Qin, C., An, L., & Lin, X. (2025) · Current Microbiology · doi:10.1007/s00284-025-04580-9 · Cited by 5
“However, some studies have indicated that certain Lactobacillus strains may lead to bacteraemia and sepsis in susceptible patients [31].”
Nguyen, Q.-D., Thi, H. T. T., Thi, N. H. N., Nguyen, V.-L., Nguyen, M. B., & Do, A. D. (2025) · Food Biotechnology · doi:10.1080/08905436.2025.2581877 · Cited by 3
“…while probiotics are widely recognized for their health benefits, they also pose certain risks that warrant careful consideration including sepsis (Kullar et al. 2023), adverse metabolic activity (Ban et al. 2020), and the transfer of antibiotic-resistance genes (Rokon-Uz-Zaman et al. 2023).”
Vaghela, P., Dave, B. P., Dabhade, A., Deshmukh, R., Prajapati, B. G., Alsaidan, O. A., Patel, S., Mehta, A., Singh, A., & Dudhat, K. R. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02254-5 · Cited by 3
“The patient developed fever, flushing, and chills one week following the initiation of Lacticaseibacillus rhamnosus GG probiotics (Vahabnezhad et al. 2013; Kullar et al. 2023).”
Zhao, M., Hou, J., Wang, J., Zhu, X., Zou, A., Wang, Y., Liu, Z., & Xianyu, Y. (2026) · Small · doi:10.1002/smll.73858 · Cited by 2
Bohra, R., Bhardwaj, K., & Rajawat, N. K. (2026) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2026.100027 · Cited by 2
Effects of CRAMP on the gut-brain axis in experimental sepsis
Bruzaferro, E. V. M., de Lima, T. M., Ariga, S. K., Barbeiro, D. F., Barbeiro, H. V., & da Silva, F. P. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106906 · Cited by 2
Santoiemma, P. P., Cohn, S. E., Gatesy, S. W. M., Hauser, A. R., Agrawal, S., Theodorou, M. E., Bachta, K. E. R., & Ozer, E. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300843 · Cited by 5
2-es típusú cukorbetegség és Alzheimer-kór − közös mikrobiális gyökerek?
Fekete, C., Schandl, L., Tomasics, G., Egey, A., Kis, J. T., & Winkler, G. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33128 · Cited by 1
Won, S., Jeong, Y., Kim, J.-E., Kim, J., Song, H. S., Bae, H.-H., Kwak, M., Kim, D., Sung, M., & Kwak, S. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2411.11069 · Cited by 4
Davidson, S., So, Y., Oscarsson, E., Håkansson, Å., & Sjöberg, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-07535-z · Cited by 1
Xue, M., Du, F., He, L., Hu, J., Li, Y., Yuan, L., Zeng, S., & Yuan, Y. (2025) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545825500300 · Cited by 2
Shibata, Y., Asai, N., Hagihara, M., & Mikamo, H. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102794 · Cited by 2
Gut allies against metabolic disorders: the therapeutic promise of probiotics
Ashaolu, T. J., & Le, T. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01371-4 · Cited by 1
Punithavathy, R., Pavithra, R., Kanimozhi, N. V., Sonali, L., Suneetha, C., & Sukumar, M. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/6534832 · Cited by 1
“As a result, robust, standardized, large-scale clinical trials are needed to establish reliable guidelines [100] 12.”
Sornsenee, P., Kooltheat, N., Pattaranggoon, N. C., Surachat, K., Monteil, A., & Romyasamit, C. (2025) · Life · doi:10.3390/life15121866 · Cited by 2
“Lacticaseibacillus paracasei is widely recognized for its ability to promote intestinal health, enhance immune responses, and modulate host–microbe interactions [44].”
Balaji, Y., & Ravi, S. N. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100960 · Cited by 4
Ye, Y., Shen, J., & Zhilong, X. (2025) · Synthetic biology and engineering · doi:10.70322/sbe.2025.10020 · Cited by 1
Mercer, E. M., Piché‐Choquette, S., Gorospe, J., Rangipour, Z., Asbury, M. R., Alshaikh, B. N., Sycuro, L. K., Kembel, S. W., Giesbrecht, G. F., & Arrieta, M. (2025) · Gut Microbiology · doi:10.1016/j.gutmic.2025.100004 · Cited by 2
Li, T.-L., Li, M., Yang, X.-M., Wei, J., & Huang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1718333 · Cited by 1
Kushima, N., Yanagihara, T., Koga, K., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12971-x · Cited by 1
Herrera-Cardoso, E. D., Tapia-Cervantes, K. A., Cepeda–Negrete, J., Gutiérrez‐Vargas, S., & León‐Galván, M. F. (2026) · BMC Genomics · doi:10.1186/s12864-026-12798-5 · Cited by 2
“Although L. plantarum is generally considered safe, some strains have been implicated in rare cases of bacteremia, especially in immunocompromised individuals [81, 82].”
Postbiotics from lactic acid bacteria as promising alternatives against urinary tract pathogens
D’Almeida, R. E., Grillo-Puertas, M., Robles, L. R., Hebert, E. M., Rapisarda, V. A., & Villegas, J. M. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1741001 · Cited by 1
“Although many studies have demonstrated the health benefits of host-related consumption of probiotics, their clinical application in immunocompromised patients remains limited due to the risk of bacteremia caused by species such as Lactobacillus (Kothari et al., 2019; Kullar et al., 2023).”
Zhou, Y., Huang, Y., & Bi, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1784251 · Cited by 2
“…are generally safe at population level, invasive infections and bacteremia attributable to probiotic-associated organisms have been documented in susceptible, severely ill, or immunocompromised patients, and barrier disruption is repeatedly cited as a facilitating context (Kullar et al., 2023).”
Liu, S., Wang, M., Sun, X., Jia, Z., & Huang, K. (2026) · Metabolites · doi:10.3390/metabo16040259 · Cited by 1
“Although lactobacilli have a long history of use and are widely regarded as safe in general populations, bacteremia and sepsis attributable to certain Lactobacillus strains have been reported in immunocompromised or critically ill patients [115].”
Dong, J., Cao, Y., Chen, X., Xie, T., Zhang, X., Zhao, Q., Shi, C., Miao, Q., Xu, Z., Yan, L., et al. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01408-x · Cited by 1
“However, the clinical translation of probiotic therapy faces challenges, including low survival rate after oral administration, colonization resistance within the dysbiotic gut, and safety concerns regarding optimal strain selection in immunocompromised patients [10–13].”
ISKANDAR, K., Marchin, L., & Roques, C. G. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1836448 · Cited by 2
“Detected Lactobacilli may rarely cause bacteremia in immunocompromised patients (Astley et al., 2023; Kullar et al., 2023).”
Nieto, Á. A. V., Díaz, A. H., Millán, M. H., Sagredo, D., & Gacitúa, J. A. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110424 · Cited by 3
Goyal, S. P., Sari, T. P., Badgujar, P. C., Chandratre, G. A., Kondepudi, K. K., & Dhewa, T. (2026) · Brazilian Journal of Microbiology · doi:10.1007/s42770-026-01940-w · Cited by 1
“…as opportunistic pathogens, and concerns exist regarding the horizontal transfer of antimicrobial resistance genes to commensal and pathogenic microbiota in fermented foods and the gastrointestinal tract, as well as rare cases of endocarditis and bacteraemia in susceptible individuals [14–17].”
Probiotic characterization of Ligilactobacillus murinus ZQL11 isolated from healthy dog feces
Gong, D., Zhang, L., 洪连鸿, Mo, S., Hu, R., Wang, X., & Zhang, J. (2026) · Veterinary Research Communications · doi:10.1007/s11259-026-11337-7 · Cited by 1
“In addition to these functional properties, safety is also a fundamental prerequisite for probiotic selection, and candidate strains should be non-hemolytic and exhibit appropriate antimicrobial susceptibility (Kullar et al. 2023, Pierro et al. 2023).”
Jiang, C., Wang, K. Z., & Yao, Y. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11061-3 · Cited by 2
Metadata
- Authors
- Kullar, R., Goldstein, E. J. C., Johnson, S., & McFarland, L. V.
- Affiliations
- Expert Stewardship Inc., Newport Beach, CA 92663, USA
- R.M. Alden Research Laboratory, Santa Monica, CA 90404, USA
- Edward Hines, Jr. VA Hospital (US)
- McFarland Consulting, Seattle, WA 98115, USA
- Corresponding author
- McFarland, Lynne V.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2023-03-30
- Volume
- 11
- Issue
- 4
- Pages
- 896
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC10145752
- OpenAlex
- W4361274209
- Cited by
- 156
- References
- 80
- Citations by year
- 2026: 47 · 2025: 52 · 2024: 47 · 2023: 10
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bio-K+
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- probiotics, probiotic safety, Lactobacillus rhamnosus GG, Lactobacillus plantarum, Lactobacillus paracasei, central venous catheters, immunosuppression, intensive care unit admission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.